The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US
Open accessAbstract
Importance: Little is known about the association between the coronavirus disease 2019 (COVID-19) pandemic and the level and content of primary care delivery in the US. Objective: To quantify national changes in the volume, type, and content of primary care delivered during the COVID-19 pandemic, especially with regard to office-based vs telemedicine encounters. Design, Setting, and Participants: Analysis of serial cross-sectional data from the IQVIA National Disease and Therapeutic Index, a 2-stage, stratified nationally representative audit of outpatient care in the US from the first calendar quarter (Q1) of 2018 to the second calendar quarter (Q2) of 2020. Main Outcomes and Measures: Visit type (office-based or telemedicine), overall and stratified by patient population and geographic region; assessment of blood pressure or cholesterol measurement; and initiation or continuation of prescription medications. Results: In the 8 calendar quarters between January 1, 2018, and December 31, 2019, between 122.4 million (95% CI, 117.3-127.5 million) and 130.3 million (95% CI, 124.7-135.9 million) quarterly primary care visits occurred in the US (mean, 125.8 million; 95% CI, 121.7-129.9 million), most of which were office-based (92.9%). In 2020, the total number of encounters decreased to 117.9 million (95% CI, 112.6-123.2 million) in Q1 and 99.3 million (95% CI, 94.9-103.8 million) in Q2, a decrease of 21.4% (27.0 million visits) from the average of Q2 levels during 2018 and 2019. Office-based visits decreased 50.2% (59.1 million visits) in Q2 of 2020 compared with Q2 2018-2019, while telemedicine visits increased from 1.1% of total Q2 2018-2019 visits (1.4 million quarterly visits) to 4.1% in Q1 of 2020 (4.8 million visits) and 35.3% in Q2 of 2020 (35.0 million visits). Decreases occurred in blood pressure level assessment (50.1% decrease, 44.4 million visits) and cholesterol level assessment (36.9% decrease, 10.2 million visits) in Q2 of 2020 compared with Q2 2018-2019 levels, and assessment was less common during telemedicine than during office-based visits (9.6% vs 69.7% for blood pressure; P < .001; 13.5% vs 21.6% for cholesterol; P < .001). New medication visits in Q2 of 2020 decreased by 26.0% (14.1 million visits) from Q2 2018-2019 levels. Telemedicine adoption occurred at similar rates among White individuals and Black individuals (19.3% vs 20.5% of patient visits, respectively, in Q1/Q2 of 2020), varied by region (low of 15.1% of visits [East North Central region], high of 26.8% of visits [Pacific region]), and was not correlated with regional COVID-19 burden. Conclusions and Relevance: The COVID-19 pandemic has been associated with changes in the structure of primary care delivery, with the content of telemedicine visits differing from that of office-based encounters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
The socio-economic implications of the coronavirus pandemic (COVID-19): a review
Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., Agha, M., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.04.018 · Cited by 6,351
The National Committee for Quality Assurance
Iglehart, J. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609263351322 · Cited by 1,824
Evaluating barriers to adopting telemedicine worldwide: A systematic review
Scott Kruse, C., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16674087 · Cited by 1,735
Telemedicine, Telehealth, and Mobile Health Applications That Work: Opportunities and Barriers
Weinstein, R. S., Lopez, A. M., Joseph, B. A., Erps, K. A., Holcomb, M., Barker, G. P., & Krupinski, E. A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.09.032 · Cited by 594
Increasing off‐label use of antipsychotic medications in the United States, 1995–2008
Alexander, G. C., Gallagher, S. A., Mascola, A., Moloney, R. M., & Stafford, R. S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2082 · Cited by 423
Self-citationAn Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
Alexander, G. C., Stoller, K. B., Haffajee, R. L., & Saloner, B. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1141 · Cited by 377
Self-citationThe Empirical Foundations of Telemedicine Interventions in Primary Care
Bashshur, R. L., Howell, J. D., Krupinski, E. A., Harms, K. M., Bashshur, N., & Doarn, C. R. (2016) · Telemedicine and e-Health · doi:10.1089/tmj.2016.0045 · Cited by 370
LaVeist, T. A. (1994) · Europe PMC (PubMed Central) · Cited by 355
Bramer, C. A., Kimmins, L. M., Swanson, R., Kuo, J., Vranesich, P., Jacques-Carroll, L. A., & Shen, A. K. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6920e1 · Cited by 297
The underutilization of cardiacmedications of proven benefit, 1990 to 2002
Stafford, R. S., & Radley, D. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02670-0 · Cited by 286
Self-citationImpact of FDA Black Box Advisory on Antipsychotic Medication Use
Dorsey, E. R. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.456 · Cited by 240
López, L., Green, A. R., Tan-McGrory, A., King, R. S., & Betancourt, J. R. (2011) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(11)37055-9 · Cited by 190
Racial disparities in health information access: resilience of the digital divide
Lorence, D. P., Park, H., & Fox, S. (2006) · Journal of Medical Systems · doi:10.1007/s10916-005-9003-y · Cited by 184
The Business of Medicine in the Era of COVID-19
Cutler, D., Nikpay, S., & Huckman, R. S. (2020) · JAMA · doi:10.1001/jama.2020.7242 · Cited by 73
Challenges And Opportunities Faced By Large Health Systems Implementing Telehealth
Ellimoottil, C. S., An, L. C., Moyer, M. F., Sossong, S., & Hollander, J. E. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.05099 · Cited by 64
Mehta, H. B., Ehrhardt, S., Moore, T. J., Segal, J. B., & Alexander, G. C. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039978 · Cited by 54
Self-citationHow Will COVID-19 Affect the Health Care Economy?
Cutler, D. (2020) · JAMA Health Forum · doi:10.1001/jamahealthforum.2020.0419 · Cited by 50
Telemedicine’s Role in Addressing the Opioid Epidemic
Yang, Y. T., Weintraub, E., & Haffajee, R. L. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.001 · Cited by 43
National Trends in Ambulatory Asthma Treatment, 1997–2009
Higashi, A. S., Zhu, S., Stafford, R. S., & Alexander, G. C. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1796-4 · Cited by 37
Self-citation
Cited by
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Shifts in office and virtual primary care during the early COVID-19 pandemic in Ontario, Canada
Glazier, R. H., Green, M. E., Wu, F. C., Frymire, E., Kopp, A., & Kiran, T. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202303 · Cited by 382
Metadata
- Authors
- Alexander, G. C., Tajanlangit, M., Heyward, J., Mansour, O., Qato, D. M., & Stafford, R. S.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-10-02
- Volume
- 3
- Issue
- 10
- Pages
- e2021476
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3091142479
- Cited by
- 468
- References
- 22
- FWCI
- 61.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.